Abstract:
La présente invention concerne un conjugué de formule A−R 1 −N (H) −N (CH 2 −C (=O) −R 2 −B) 2 dans laquelle A représente une entité fonctionnelle; B représente une entité de ciblage; et R 1 et R 2 , identiques ou différents, représentent, chacun une liaison ou un groupement de liaison comprenant de 1 à 40 atomes de carbone et notamment de 1 à 30 atomes de carbone. La présente invention concerne un procédé de préparation d'un tel conjugué et son utilisation en médecine ou dans le diagnostic.
Abstract:
The present invention relates to pharmaceutical formulations comprising specific hydrazidomycin compounds. Since said hydrazidomycin compounds show cytotoxic activities, the present invention further relates to said hydrazidomycin compounds for use in medicine, in particular in the treatment of proliferative disorders.
Abstract:
In one aspect, the invention relates to compounds having the formula: (I) where R 1 -R 6 , a, b, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
Abstract:
Oleamide is an endogenous fatty acid primary amide that possesses sleep-inducing properties in animals and has been shown to effect seratonergic systems and block gap junction communication in a structurally specific manner. Certain agents can serve both as an oleamide agonist and as an inhibitor of fatty acid amide hydrolase. Fatty acid amide hydrolase is responsible for the rapid inactivation of oleamide in vivo. The structural features of oleamide required for inhibition of gap junction-mediated chemical and electrical transmission in rat glial cells are defined. Effective inhibitors fall into two classes of fatty acid primary amides of which oleamide and arachidonamide are the prototypical members. Of these two, oleamide constitutes the most effective and its structural requirements for inhibition of the gap junction are well defined. It requires a chain length of 16-24 carbons of which 16-18 carbons appears optimal, a polarized terminal carbonyl group capable of accepting but not necessarily donating a hydrogen bond, a DELTA 9 cis double bond, and a hydrophobic methyl terminus. Within these constraints, a range of modifications are possible, many of which may with enhanced in vivo properties.
Abstract:
The invention relates to a method for producing substituted hydroxypyrazoles and new intermediate products. It relates in particular to a method for producing compounds of formula (I) in which R is hydrogen, an aliphatic group with between 1 and 8 carbon atoms, C1-C6-alkoxycarbonyl, C1-C6-alkyl thiocarbonyl or a cyclic ring system with between 3 and 14 ring atoms; R is hydrogen, an aliphatic group with between 1 and 8 carbon atoms; or R and R together with the carbon atom to which they are bound are a cyclic or bicyclic ring system with between 3 and 14 ring atoms. Said method comprises the production, as starting or intermediate products, of compounds of formula (II) in which R and R are readily cleavable groups and R and R have the meanings given above. Said compounds are cyclized under suitable reaction conditions to yield compounds of formula (I).
Abstract:
Oleamide is an endogenous fatty acid primary amide that possesses sleep-inducing properties in animals and has been shown to effect seratonergic systems and block gap junction communication in a structurally specific manner. Certain agents can serve both as an oleamide agonist and as an inhibitor of fatty acid amide hydrolase. Fatty acid amide hydrolase is responsible for the rapid inactivation of oleamide in vivo. The structural features of oleamide required for inhibition of gap junction-mediated chemical and electrical transmission in rat glial cells are defined. Effective inhibitors fall into two classes of fatty acid primary amides of which oleamide and arachidonamide are the prototypical members. Of these two, oleamide constitutes the most effective and its structural requirements for inhibition of the gap junction are well defined. It requires a chain length of 16-24 carbons of which 16-18 carbons appears optimal, a polarized terminal carbonyl group capable of accepting but not necessarily donating a hydrogen bond, a DELTA 9 cis double bond, and a hydrophobic methyl terminus. Within these constraints, a range of modifications are possible, many of which may with enhanced in vivo properties.
Abstract:
Fluorinated alkene compounds useful for and methods of controlling nematodes, insects, and acarids that prey on agricultural crops. Polar compounds, for example, 3,4,4-trifluoro-3-butene-1-amine or 3,4,4-trifluoro-3-butenoic acid, are particularly useful for systemic control of pests. Novel method and intermediates for the preparation of 3,4,4-trifluoro-3-butene-1-amine are also provided.